Bacillus anthracis is a Gram-positive, spore-forming bacterium that is the etiological agent of anthrax, a severe zoonotic disease affecting humans and a wide range of animals. It is a member of the Bacillus cereus sensu lato group and is distinguished by its high virulence, ability to form highly resistant spores, and historical significance as both a naturally occurring pathogen and a potential bioterrorism agent.

Anthrax has been recognized since antiquity and remains relevant in modern medicine and public health due to its persistence in the environment, occupational risks in animal handling industries, and potential for deliberate release. Despite being rare in many high-income countries, it continues to cause sporadic outbreaks globally, particularly in regions with limited veterinary control and vaccination coverage in livestock.

From a biological standpoint, Bacillus anthracis is notable for its dual lifestyle: a vegetative form that replicates within host organisms and a dormant spore form that can survive in soil for decades. This environmental persistence is central to its epidemiology and long-term public health impact.

The pathogenicity of B. anthracis is primarily mediated by two key factors: a tripartite exotoxin system and a poly-D-glutamic acid capsule. These virulence determinants enable immune evasion, tissue destruction, and systemic dissemination.

Biological Characteristics of Bacillus anthracis

Bacillus anthracis is a rod-shaped bacterium, typically occurring singly or in chains. It is non-motile, a feature that helps distinguish it from closely related Bacillus species such as Bacillus cereus. It is also catalase-positive and aerobic or facultatively anaerobic under certain conditions.

Spore Formation and Environmental Persistence

One of the defining features of B. anthracis is its ability to form endospores under nutrient-limiting conditions. These spores are highly resistant to heat, desiccation, radiation, and many disinfectants.

Spores can remain viable in soil for decades, particularly in alkaline environments rich in organic matter. This long-term persistence contributes to the re-emergence of anthrax in livestock grazing areas long after initial contamination events.

Upon entry into a suitable host, spores germinate into vegetative bacilli, initiating infection and toxin production.

Capsule and Immune Evasion

Unlike most Gram-positive bacteria, B. anthracis produces a capsule composed of poly-D-glutamic acid rather than polysaccharides. This capsule inhibits phagocytosis by host immune cells.

The capsule is encoded on a plasmid (pXO2), while toxin genes are located on a separate plasmid (pXO1), both of which are essential for full virulence.

Anthrax Toxin System

The anthrax toxin is composed of three protein components: protective antigen (PA), edema factor (EF), and lethal factor (LF). These components act in combination to disrupt host cellular function.

Protective antigen binds to host cell receptors and facilitates entry of the enzymatic components into cells. Edema factor is a calmodulin-dependent adenylate cyclase that increases intracellular cyclic AMP, leading to fluid imbalance and edema.

Lethal factor is a zinc-dependent protease that disrupts MAP kinase signaling pathways, leading to macrophage death and systemic toxicity.

Transmission and Epidemiology

Bacillus anthracis is primarily a zoonotic pathogen, meaning it is transmitted from animals to humans. Herbivorous mammals such as cattle, sheep, goats, and wild ungulates are the main reservoirs.

Environmental and Soil Transmission

Spores enter the environment through the carcasses of infected animals. When animals ingest or inhale spores from contaminated soil, infection can occur.

Environmental outbreaks are often associated with soil disturbance, drought followed by heavy rainfall, or changes in grazing patterns that expose buried spores.

Human Routes of Infection

Human anthrax occurs through three primary routes: cutaneous, inhalational, and gastrointestinal exposure.

Cutaneous anthrax results from spores entering through skin abrasions and is the most common form. Inhalational anthrax results from inhalation of spores and is the most lethal form. Gastrointestinal anthrax results from ingestion of contaminated meat.

Occupational Risk Factors

Individuals at highest risk include farmers, veterinarians, abattoir workers, and those handling animal hides, wool, or bone products.

Pathogenesis and Effects on Human Health

Anthrax disease severity depends on the route of exposure, bacterial load, and speed of immune response. Once spores germinate, rapidly multiplying vegetative cells produce toxins that drive systemic disease.

Cutaneous Anthrax

Cutaneous anthrax begins as a pruritic papule that progresses to a vesicle and eventually a characteristic black necrotic eschar. Surrounding edema is often extensive but typically painless.

Without treatment, mortality is low compared to other forms, but systemic dissemination can occur in severe cases.

Inhalational Anthrax

Inhalational anthrax begins with nonspecific flu-like symptoms, followed by rapid progression to severe respiratory distress, mediastinal widening, septic shock, and often death if untreated.

Spores are taken up by alveolar macrophages and transported to mediastinal lymph nodes, where germination occurs and systemic toxin release follows.

Gastrointestinal Anthrax

Gastrointestinal anthrax results from ingestion of contaminated meat and presents as severe abdominal pain, vomiting, hemorrhagic diarrhea, and systemic infection.

Immune Response and Host–Pathogen Interaction

The immune system responds to Bacillus anthracis through both innate and adaptive mechanisms, but the bacterium’s toxins significantly impair immune effectiveness.

Innate Immune Evasion

Spores are resistant to phagocytosis and can survive within macrophages long enough to germinate. Once vegetative cells form, toxins impair macrophage signaling and induce apoptosis.

Adaptive Immunity

Antibodies against protective antigen are particularly important for immunity, as they neutralize toxin entry into host cells.

Vaccines targeting PA are based on this immunological principle.

Antibiotic Treatment and Resistance Mechanisms

Bacillus anthracis is generally susceptible to several antibiotics, including fluoroquinolones, tetracyclines, and beta-lactams. However, antibiotic resistance can emerge through several mechanisms.

Intrinsic Susceptibility and Therapeutic Challenges

Early treatment is critical, particularly in inhalational anthrax, where disease progression is rapid once systemic dissemination occurs.

Combination therapy is often used to prevent toxin-mediated damage and bacterial proliferation simultaneously.

Mechanisms of Antibiotic Resistance

Although naturally susceptible, B. anthracis can acquire resistance through horizontal gene transfer, mutation, and plasmid acquisition from related Bacillus species such as Bacillus cereus.

Beta-lactam resistance may arise via production of beta-lactamase enzymes that hydrolyze the antibiotic ring structure, rendering the drug ineffective.

Efflux pumps can also contribute by actively exporting antibiotics from bacterial cells, reducing intracellular drug concentrations.

Target site mutations in DNA gyrase or RNA polymerase can confer resistance to fluoroquinolones and rifampin, respectively.

Plasmid-Mediated Resistance

Like many bacteria, B. anthracis can acquire resistance genes on plasmids, which may be transferred between related species in the environment.

This raises concern for the potential emergence of multidrug-resistant anthrax strains, particularly in environments where antibiotic exposure is frequent.

Diagnosis and Laboratory Identification

Diagnosis of anthrax involves microbiological culture, molecular testing, and serological assays.

Culture and Microscopy

B. anthracis grows readily on standard laboratory media, producing large, non-hemolytic colonies with a characteristic “medusa head” appearance.

Gram staining reveals large Gram-positive rods, often in chains.

Molecular Diagnostics

PCR assays targeting plasmid genes (pXO1 and pXO2) are used for rapid and specific identification of virulent strains.

Prevention and Public Health Importance

Anthrax remains a significant public health concern due to its environmental persistence, occupational exposure risks, and potential use as a bioterrorism agent.

Vaccination

Vaccines based on protective antigen are used in high-risk populations, including military personnel and certain occupational groups.

Veterinary Control

Vaccination of livestock is a key strategy for preventing environmental contamination and human infection.

Environmental Management

Proper disposal of infected animal carcasses and decontamination of affected areas are critical for controlling outbreaks.

Bioterrorism and Security Considerations

Bacillus anthracis spores have been used as a biological weapon due to their stability, ease of dissemination, and high lethality in inhalational form.

This has led to increased surveillance, laboratory preparedness, and biodefense research worldwide.

Research Directions and Future Challenges

Ongoing research focuses on improving vaccine efficacy, developing novel antitoxin therapies, and understanding spore germination mechanisms.

Advances in genomics are also helping track environmental reservoirs and evolutionary dynamics of Bacillus anthracis populations.

Conclusion

Bacillus anthracis is a highly specialized bacterial pathogen capable of causing severe disease through a combination of spore persistence, toxin production, and immune evasion. Its ability to survive in the environment for decades and cause sudden outbreaks makes it a unique and enduring public health threat.

Although effective antibiotics and vaccines exist, early detection and rapid treatment are essential for survival, particularly in inhalational anthrax. Continued vigilance, environmental control, and research into resistance mechanisms remain critical for managing this historically significant pathogen.